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Abstract: Dendrowardol C (1)—a novel sesquiterpenoid, with an unprecedented 4/5/6/6 tetracyclic carbon backbone, together with 
two known cyclopacamphane-type sesquiterpenoids; dendronobilin I (2) and dendrobane A (3) were isolated from the stems of 
Dendrobium wardianum Warner. The structure of 1 was established on the basis of spectroscopic data and the absolute configuration
was determined by single-crystal X-ray diffraction crystallography. The hypothetical biosynthetic pathway of 1 was postulated. 
Compound 1 showed no cytotoxic activity against human tumor cell lines HL-60, SMMC-7721, A-549, MCF-7, and SW480. 
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Introduction 
The stems of several Dendrobium species (Orchidaceae) are 
used in traditional Chinese medicine mainly for nourishing the 
stomach, promoting secretion of saliva, and reducing fever.1 
Dendrobium wardianum Warner is an endemic plant  
distributed mainly in southern Yunnan Province, China and 
some southeast Asian countries, i.e. Myanmar, Bangladesh, 
and Thailand.2 This plant was rarely used as ″Shi-Hu″ ever 
and previous chemical investigation on this plant has led to the 
isolation of an picrotoxane-type alkaloid, dendrowardine.3 
Recently, we have isolated three sesquiterpenoids from the 
stems of D. wardianum Warner4 and continual chemical  
investigation of the same collection of this plant led to the 
isolation of one novel sesquiterpenoid, dendrowardol C (1) 
with an unprecedented 4/5/6/6 tetracyclic ring system, together 
with two known cyclopacamphane-type sesquiterpenoids. The 
new structure was determined on the basis of extensive  
spectroscopic analysis and the X-ray crystallographic  
diffraction analysis, while the known sesquiterpenoids were 
identified as dendronobilin I (2)5 and dendrobane A (3)6 by 
comparison with the literatures. In addition, the hypothetical 
biosynthetic pathway of 1 was postulated. 
 
Results and Discussion 
Compound 1 was isolated as a colorless crystal (MeOH). Its 
molecular formula (C15H24O3), was established on the basis of 
HRESIMS from the [M + Na]+ ion at m/z 275.1627 (calcd. for 
275.1623), indicating four degrees of unsaturation. The 1H 
NMR spectrum of 1 (Table 1) indicated the existence of two 
methyl groups [δH 1.71 (3H, s), 1.19 (3H, d, J = 6.6 Hz)]. The 
13C NMR (DEPT) spectra of 1 (Table 1) revealed 15 carbon 
signals arising from two quaternary carbons (one oxygenated), 
seven methines (one oxygenated), four methylenes (one  
oxygenated) and two methyls. Since no C=O and C=C double 
bonds were dectected according to 13C NMR and IR data, a 
tetracyclic structure was required for 1 to fulfill the four 
degrees of unsaturation. The comparison of 1H and 13C NMR 
spectra data of 1 (Table 1) with those of dendronobilin I (2) 
suggested that 1 and 2 were similar in rings B and C, indicating
the similar structure of 1 and 2. For the cyclopacamphane-type 
sesquiterpene in Dendrobium species, C-3 is usually a  
quaternary carbon without oxygen and C-15 is constantly a 
methyl or an oxygenated methylene.5–7 Interestingly, an  
oxygenated quaternary carbon (δC 78.1) and a methylene  
carbon (δC 35.2) signals appeared in 13C NMR (DEPT)  
spectrum of compound 1. From the HSQC spectral data of 1, 
twenty-one protons were assigned unambiguously to thirteen 
carbons, respectively. The partial structure (rings B and C) 
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was constructed by 1H-1H COSY correlations of H-1/H-2/H-
5/H-6/H-7, H-1/H-7, and H-9/H-10/H-11/H-1, and HMBC 
correlations from H-9 to C-7 and C-8, from Me-15 to C-7 and 
C-8. The HMBC (Figure 1) correlations of H-1, H-2 and H-4 
(δH 2.25, 3.08) with C-3 (δC 78.1), as well as 1H-1H COSY 
correlation of H-4/H-5, indicated the linkage of C-2/C-3/C-4, 
which established a four-membered ring C system. 
Furthermore, the cross-peak of Me-15/C-3 displayed the 
connecting of C-8/C-3. These data were in good agreement 
with the spectral data observed for C-3 (an oxygenated 
quaternary carbon) and C-4 (an methylene carbon). The other 
correlations in 1H-1H COSY spectrum revealed the fragments 
of C-13/C-12/C-14 and C-11/C-12. Thus, the planar structure 
of 1 with a novel 4/5/6/6 tetracyclic ring system was proposed 
as shown in Figure 1. 
The correlations of H-1/H-7, H-7/H-11, and H-1/H-6, were 
observed from the ROESY spectrum (Figure 1), which  
revealed that H-1, H-7, H-11 and OH-6 were α-, α-, α-, β-
oriented, respectively. Since C-3 (in ring A system) was  
established to be connected to C-8 (in ring C system) in the 
structure of 1 with a 4/5/6/6 tetracyclic carbon skeleton, Me-
15, H-2, and H-5 should be on the same side as H-1 and H-6, 
possessing α-orientation. Both Me-15 and H-5 were α-oriented, 
which was also supported by the correlations of H-7/Me-15 
and H-5/H-6 in the ROESY spectra. Thus, the relative  
configurations of all chiral carbons in the molecule except for 
C-12 were determined as the configuration of the stereocenter 
at C-12 could not be determined due to free rotation of this 
center with the C-11–C-12 bond5. 
To characterize the absolute configuration of 1, a proper  
crystal was obtained using an applied single crystal X-ray  
diffraction with Cu Kα radiation. As shown in Figure 2, the 
absolute configurations at C-1, 2, 3, 5, 6, 7, 8, 11, and 12 were 
deduced as 1R, 2R, 3R, 5R, 6R, 7R, 8S, 11R, and 12S based on  
X-ray crystallographic data (CCDC-896832). 
The presence of the two structurally related sesquiterpenoids
(1 and 2) in the same plant implied that dendrowardol C (1) 
might be derived from the sesquiterpene cyclosativene.8 The 
compound was oxidized to intermediate a, then dehydration 
under acidic conditions to intermediate c. After a Wagner-
Meerwein rearrangement via C3–C4 bond-shift to give an 
intermediate,9 cyclobutyl cation (d), which was then attacked 
by H2O as the nucleopilic reagent and then underwent  
deprotonation and get the compound 1 (as shown in Scheme 1). 
Compound 1 was assayed for its cytotoxicity against five 
human cancer cell lines (HL-60, SMMC-7721, A-549, MCF-7, 
and SW480) by the MTT assay method, with DDP and taxol 
as positive controls. The results showed that compound 1  
exhibited no significant cytotoxic activity against the above 
cell lines at the concentration of 40 μM. 
 
Experimental Section 
General Experimental Procedures. Melting points were 
obtained on an X-4 micro melting point apparatus. Optical 
rotations were measured with a Horiba SEPA-300 polarimeter. 
UV spectra were obtained using a Shimadzu UV-2401A  
spectrometer. IR spectra were recorded on a Bruker FT-IR 
Tensor 27 spectrometer using KBr pellets. 1D and 2D NMR 
Table 1. 1H NMR data of compound 1 and 13C NMR data of 




δH δC δC 
1 2.12 (br. s) 44.6 d 41.9 d 
2 2.89 (br. d, 4.2) 53.9 d 19.3 d 
3  78.1 s 30.8 s 
4a 2.25 (br. t, 8.8) 35.2 t 23.9 d
4b 3.08 (br. d, 9.7)   
5 2.41 (m) 31.3 d 78.1 d 
6 4.40 (m) 76.2 d 52.4 d 
7 1.91 (br. s) 55.6 d 44.9 s 
8  46.3 s 35.6 t 
9a 1.40 (m) 38.4 t  
9b 2.18 (overlapped)  23.7 t 
10a 1.72 (overlapped) 25.1 t 38.6 d 
10b 2.16 (overlapped)   
11 1.89 (m) 38.5 d 39.9 d 
12 1.75 (overlapped) 40.7 d 65.7 t
13a 3.77 (dd, 10.4, 6.6) 65.8 t 15.5 q 
13b 3.96 (dd, 10.4, 4.0)   
14 1.19 (d, 6.6) 15.7 q 22.7 q 
15 1.71 (s) 19.8 q 59.5 t 
a1H NMR recorded at 500 MHz, 13C NMR recorded at 125 MHz; 
b13C NMR recorded at 100 MHz. 
 
Figure 2.  X-ray structure of 1 
 
Figure 1.  Key 1H-1H COSY, HMBC and ROESY correlations
of 1  
Scheme 1.  Plausible biogenetic pathway of 1 
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spectra were recorded on Bruker Avance III 600 MHz, Bruker 
DRX-500 MHz, or AV-400 MHz spectrometers with TMS as 
the internal standard. Chemical shifts (δ) are expressed in ppm 
relative to TMS. HREIMS was recorded on a Waters Auto 
Premier P776 spectrometer. Positive HRESIMS experiments 
were carried out on a VG Autospec-3000 spectrometer under 
70 eV and a LCMS-IT-TOF (Shimadzu, Kyoto, Japan).  
Column chromatography (CC) was carried out using silica gel 
(200–300 mesh) and TLC was carried out on plates precoated 
with silica gel (10–40 μm, Qingdao Marine Chemical Ltd., 
Qingdao, China). RP-18 gel (40–63 μm, Merck, Darmstadt, 
Germany), and Sephadex LH-20 was purchased from  
Amersham Biosciences. 
 
Plant Material. The D. wardianum Warner plants were 
purchased in August 2009 from Puer, Yunnan Province and 
identified by Dr. Xiao-Hua Jin of Institute of Botany, Chinese 
Academy of Sciences. A voucher specimen (No. Zsh-7) was 
preserved at the State Key Laboratory of Phytochemistry and 
Plant Resource in West China, Kunming Institute of Botany, 
CAS, China. 
 
Extraction and Isolation. The fresh stems of D. wardianum
Warner (50 Kg) were extracted with 95% EtOH (24 L × 3) and 
the ethanol solution was concentrated to a water suspension 
under reduced pressure by rotary evaporator and then  
partitioned between CHCl3 and HCl/H2O (pH 2). The aqueous 
layer was adjusted to pH = 10 with 1 M sodium hydroxide 
solution and then extracted with CHCl3 to give an alkaloidal 
extract (6.0 g). The aqueous phase was then subjected to 
macroporous resin (D101) chromatography to afford the crude 
water-soluble material (92.0 g). The water soluble material 
was subjected to silica gel column chromatography (CC) 
(CHCl3/MeOH, 30:1, 20:1, 15:1, 10:1, 5:1, 0:1) to afford  
fractions I−VII. Fraction III (8.5 g) was subjected to CC over 
silica gel (CHCl3-MeOH, from 20:1 to 2:1), Sephadex LH-20 
chromatography (MeOH), RP-18 CC (MeOH/H2O, 1:4−1:0) 
and further purified through recrystallization from MeOH to 
yield 1 (5 mg) and dendronobilin I (2) (4 mg). Similarly,  
fraction VI (8.9 g) was purified through repeated  
chromatography to afford dendrobane A (3) (2 mg). 
 
Dendrowardol C (1): mp 193–194 oC; [α]20.7D   + 48.64 (c 
0.26, MeOH); UV (MeOH) λmax (log ε): 203 (2.59) nm; IR 
(KBr) νmax 3499, 2960, 2935, 2900, 2871, 2828, 1456, 1381, 
1283, 1269, 1032, 762 cm–1; 1H and 13C NMR data, see Table 
1; ESIMS m/z 275 [M + Na]+, HRESIMS m/z 275.1627 (calcd. 
for C15H24O3Na, 275.1623). 
 
Crystallographic Data of Dendrowardol C (1): C15H24O3, 
M = 252.34; orthorhombic system, space group P212121, a = 
6.39120(1) Å, b = 11.8518(2) Å, c = 18.2414(3) Å, α = β = γ = 
90º, V = 1381.74(4) Å3, Z = 4, d = 1.213 g/cm3. A crystal of 
dimensions 0.90 × 0.19 × 0.18 mm3 was used for measurement 
on a Bruker APEX DUO with a graphite monochromater, Cu 
Kα radiation. Reflections collected: 13935. Independent 
reflections: 13935/2522 [Rint  = 0.0384]. Completeness to θ = 
69.59º:98.3%. The structure was solved by direct methods and 
refined by a full-matrix least squares on F2. Final R indices 
[I > 2σ(I)]: R1= 0.0310, wR2 = 0.0814. Flack parameter: 
0.00(18). Crystallographic data for dendrowardol C (1) has 
been deposited at the Cambridge Crystallographic Data Centre 
as deposition number CCDC 896832. Copies of the data can 
be obtained free of charge on application to CCDC, 12 Union 
Road, Cambridge CB2 1EZ, UK (Tel: + 44 (0)1223 762911,  
e-mail: deposit@ccdc.cam.ac.uk). 
 
Cytotoxicity Assay. The following human tumor cell lines 
were used: HL-60, SMMC-7721, A-549, MCF-7, and SW480. 
All the cells were cultured in RMPI-1640 or DMEM medium 
(Hyclone, Logan, UT), supplemented with 10% fetal bovine 
serum (Hyclone) at 37 °C in a humidified atmosphere with 5% 
CO2. Cell viability was assessed by conducting colorimetric 
measurements of the amount of insoluble formazan formed in 
living cells based on the reduction of 3-(4,5-dimethylthiazol-2-
yl)-2,5-diphenyltetrazolium bromide (MTT) (Sigma, St. Louis, 
MO). Briefly, 100 μL of adherent cells were seeded into each 
well of a 96-well cell culture plate and allowed to adhere for 
12 h before drug addition, while suspended cells were seeded 
just before drug addition, both with an initial density of 1 × 
105 cells/mL in 100 μL of medium. Each tumor cell line was 
exposed to the test compound at various concentrations in 
triplicate for 48 h, with DDP and toxal as positive controls. 
After the incubation, MTT (100 μg) was added to each well, 
and the incubation continued for 4 h at 37 °C. The cells were 
lysed with 200 μL SDS after the removal of 100 μL of medium. 
The optical density of the lysate was measured at 595 nm in a 
96-well microtiter plate reader (Bio-Rad 680). The IC50 value 
was calculated by the Reed and Muench’s method.10 
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